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Differential Regulation of Liver P-450111 Cytochromes in 
Choline-deficient Rats: Implications for the Erythromycin 
Breath Test as a Parameter of Liver Function 
Progressive liver fibrosis in rats develops when they 
are fed a diet deficient in choline. This diet also results 
in a pronounced and selective decrease in the liver 
microsomal content of a phase I drug-metabolizing 
enzyme belonging to the cytochrome P-450111 gene 
family. Because P-450111 cytochromes characteristi- 
cally catalyze the N-demethylation of erythromycin, 
we believed that the production of breath CO, 
from erythromycin would be dramatically reduced in 
choline-deficient rats. However, when 12 choline- 
deficient rats were compared with 9 control rats, the 
reduction in CO, production from erythromycin (mean 
decrease 71%) was essentially identical to that from 
aminopyrine (mean decrease 69%). a substrate be- 
lieved to be metabolized normally by the hepatocyte in 
fibrotic liver disease. Furthermore, we found that the 
relative erythromycin and aminopyrine demethylase 
activities were comparable when measured in uitro in 
liver microsomes prepared from the choline-deficient 
rats. To determine the molecular basis for the eryth- 
romycin demethylase activity in the choline-deficient 
rats, the liver microsomes were subjected to immu- 
noblot analysis using a variety of polyclonal and 
monoclonal antibodies capable of distinguishing indi- 
vidual P-450111-related proteins. Our studies confirm 
that a mdor erythromycin demethylase belonging to 
the P-45OIII family, termed P-450p, was greatly re- 
duced in the choline-deficient rat liver. However, the 
specific concentration of a second P-45Oprelated 
protein was essentially normal and that of a third 
P-45Oprelated protein was actually increased in the 
choline-deficient rat liver. These changes occurred 
over weeks and months on the choline-deficient diet 
and are not consistent with "feminization" of the liver. 
The P-45Oprelated proteins appeared to catalyze 
erythromycin demethylase activity because antibodies 
recognizing them inhibited the mqjority (62%) of this 
activity in choline-deficient rat microsomes. Finally, 
Received January 26, 1990; accepted . l u n i ,  13, I Y Y O  
This research was supportd by the Satiom;il Institutv. d H t d t h  ' ( ; M  : b l 4 ! J  
Drs. Kolars and Watkins are rtapirr i t .  111  \'tbtc*r;ws Adminlstraflrirl ( ' < i w t , i  
Address reprint requests t o  I'aul 13 M'atklns. M.1) . 6ilOl) M S K H  I 
PBWI and the Veterans AdrninisfratIon 
Devclopment Awards. 
University of Michigan Medical ('enti.i. 
Ann Arbor. MI 48109-06W 
I 150 West ,M~rd~c;il ('entvr I h w .  
3 l/l/24802 
RNA extracted from choline-deficient rat livers was 
hybridized on Northern blots with synthetic oligonu- 
cleotide probes that identify the only two known rat 
P-450111 cDNAs, PCN-1 and PCN-2. Prolonged choline 
deficiency appeared to have no consistent effects on 
expression of these RNA species. W e  conclude that 
despite the down-regulation of a major erythromycin 
demethylase, this catalytic activity is relatively pre- 
served in the choline-deficient rat, at least in part 
because of differential regulation of P-450111 cy- 
tochromes. Erythromycin therefore appears to offer 
little advantage over aminopyrine as a substrate for 
assessing liver function in this model of chronic liver 
disease. (HEPATOLOGY 1990: 12: 1371-1378.) 
The ability to metabolize many drugs is impaired in 
patients with cirrhosis. Based on this observation, it has 
been proposed that  the severity of chronic liver disease 
and cirrhosis can be quantitated in a t  least some patients 
by measuring their ability to metabolize a test dose of 
aminopyrine (reviewed in reference 11. Aminopyrine is 
demethylated in the liver by the mixed function oxidase 
system, which is made up of multiple families of 
genetically related enzymes collectively termed q- 
tochromes P-450. Because a large proportion of the 
carbon in the cleaved methyl group promptly appears in 
the breath as CO,. the ability to demethylate ami- 
nopyrine can be estimated in a patient simply as  the rate 
of production of "'CO, in the breath after administration 
of a test dose of [ ' "C  N-methyl] aminopyrine ( 2 ) .  
Enthusiasm over the potential usefulness of the ami- 
nopyrine breath test has been tempered, however, by the 
observation that  the result is influenced by many other 
concomitantly administered medications (reviewed in 
reference 1 ).  Furthermore, ethanol consumption ap- 
pears to increase the rate of production of CO, from 
aminopyrine (31, presumably by inducing liver cy- 
tochrome(s1 P-450 capable of demethylating aminopy- 
rine. The breath test may therefore be difficult to 
interpret in the large population of patients with 
alcoholic liver disease. 
We have recently described a breath test that uses 
erythromycin as a substrate ( 4 ) .  We believed that 
erythromycin might be preferable to aminopyrine as  a 
substrate for assessing liver function for two reasons. 
First, the major erythromycin demethylases in liver 
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have been identified and belong to the P-450111 gene 
family (5) .  Because P-450111 cytochromes have been 
reasonably well characterized in rat and man (6-13), 
medications likely to influence erythromycin demethy- 
lation are known (4, 6-12) and ethanol should have no 
effect (13, 14). Second, the available evidence suggested 
that in chronic liver disease and cirrhosis, the ability to 
demethylate erythromycin might be reduced to a greater 
extent than the ability to demethylate aminopyrine. 
Chronic liver disease appears to have differential effects 
on the regulation of individual cytochromes P-450 and 
their corresponding catalytic activities (15-18). More- 
over, Murray et al. (18) showed that the concentration of 
at least one major P-450111 cytochrome was less than 5% 
of normal in microsomes prepared from rats given 
fibrotic liver disease by prolonged choline deficiency. In 
the same microsomes, however, the concentrations of 
some other cytochrome P-450 proteins were essentially 
normal (18). This indicated that P-450111 cytochromes 
may be selectively down-regulated in the fibrotic liver, 
which, in turn, would be expected to result in loss of the 
hepatocyte’s intrinsic ability to demethylate erythro- 
mycin. On the other hand, Reichen et al. (19) have 
recently presented data suggesting that the hepatocyte’s 
intrinsic ability to demethylate aminopyrine is not 
significantly altered in rats with fibrotic liver disease. 
These authors proposed that the reduced ability to 
demethylate a test dose of aminopyrine in chronic liver 
disease reflects only the reduced hepatocyte mass and 
the alterations in liver blood flow that characteristically 
accompany cirrhosis. Taken together, these observa- 
tions suggested that the cytochromes P-450 involved in 
aminopyrine demethylation, which have not yet been 
identified, are probably present in near normal concen- 
tration in cirrhotic liver hepatocytes, whereas the 
concentration of forms primarily involved in erythro- 
mycin demethylation may be significantly decreased. 
Since reduction in hepatocyte mass and liver circulatory 
changes should have comparable effects on the metab- 
olism of both substrates, we reasoned that there might 
be greater impairment in production of CO, from 
erythromycin than from aminopyrine in rats with liver 
fibrosis. If so, the erythromycin breath test might 
provide a very sensitive parameter of liver function in 
chronic disease and cirrhosis. 
To test this idea, we administered the erythromycin 
and aminopyrine breath tests to groups of rats given 
fibrotic liver disease by prolonged nutritional deficiency. 
Contrary to our expectation, we found that when these 
rats were compared with healthy rats, the fall in C02 
production from each substrate was essentially iden- 
tical. To investigate the molecular basis for the relative 
preservation of P-450111 catalytic activity, the diseased 
liver microsomes were analyzed using antibodies that 
are capable of distinguishing members of the P-450111 
gene family. We confirmed that a major liver P-450111 
protein is almost completely repressed in the choline- 
deficient (CD) animals. However, the microsomal con- 
centration of a second P-450111-related protein was 
unchanged and that of a third related protein was 
actually increased. 
MATERIALS AND METHODS 
Animals and Treatments. Male, Sprague-Dawley rats (80 to 
100 gm) were obtained from Charles River, Inc., (Wilmington, 
MA) and housed two to five per cage with free access to water. 
After acclimatization, rats had free access to either a custom 
high-fat, CD chow (ICN Nutritional Biochemicals Diet 
#901387, ICN, Cleveland, OH) that was free of methionine, 
folic acid, and vitamin B,, (referred to as the “choline- 
deficient” or “CD” diet) or an identical “control” chow 
supplemented with choline chloride (165 mg/100 gm), me- 
thionine (230 mg/100 gm), folic acid (198 kg/lOO gm) and 
vitamin B,, (3 ~g/100 gm) (referred to as the “control” diet). 
Rats in both groups gained weight, but at 7 mo rats on the CD 
diet weighed 45% less than rats on the control diet (mean 398 
gm vs. 719 gm). After 2 wk to 7 mo on the diets, rats underwent 
breath tests and/or were killed by decapitation, and liver tissue 
assays were performed. 
After the animals were decapitated, the liver was perfused 
through the hepatic vein with PBS, frozen in liquid nitrogen, 
and stored at -70” C. Hepatic hydroxyproline content was 
assayed as previously described (20) from 4 gm of liver tissue 
taken from the right lobe. Hepatic hydroxyproline was elevated 
an average of 2.2-fold in livers of 13 rats maintained for 7 mo 
on the CD diet relative to the livers of 9 rats maintained on the 
supplemented diet (4.02 vs. 1.81 kmol hydroxyproline/gm 
liver; p < 0.001 according to an unpaired t test). Histological 
examination revealed normal histology in a randomly selected 
supplemented control rat, whereas fatty infiltration and 
fibrosis were present in a randomly selected CD diet animal 
(not shown). These studies confirmed that significant liver 
fibrosis had occurred as a result of the CD diet. All studies were 
approved by the University of Michigan Committee on Animal 
Use. 
Breath Tests. The erythromycin breath test (ERMBT) was 
performed essentially as described (4). Rats received tail vein 
injections of 0.5 to 1.0 pCi/lOO gm body weight [“C N-methyl1 
erythromycin (54.3 mCi/mmol, New England Nuclear Corp., 
Boston, MA) and did not concomitantly receive unlabeled 
erythromycin. Trace doses of erythromycin were used because 
the pharmacological doses given in prior studies (4) quickly 
killed the animals who had received the CD diet. The 
aminopyrine breath test (APBT) was performed by injecting 
0.5 kCi/lOO gm body weight of [“C dimethyl] aminopyrine 
(101.8 mmoVmCi, New England Nuclear Corp.) into the tail 
vein. After the tail vein injections, the rats were placed in a 
water-sealed polyurethane breath chamber and CO, was 
collected at intervals and assayed for I4C (4). The results of 
each breath test are expressed as the percent of injected I4C 
recovered during the first hour after injection. 
When both breath tests were performed on the same rats, 
the APBT was performed 24 hr before the ERMBT. Initial 
studies (not shown) indicated that the administration of the 
APBT did not influence the results of the ERMBT when the 
tests were separated by 24 hr. 
Microsomal Assays. The liver tissue remaining after hy- 
droxyproline determination was used for preparation of 
microsomes by differential centrifugation (21). Up to 100 kg of 
microsomal protein was then subjected to 10% SDS-PAGE, 
and the separated proteins were transferred to nitrocellulose 
sheets. The nitrocellulose sheets were then reacted with 
antibodies as previously described (22). The monoclonal 
antibodies 1G8 and 13-7-10 have been previously charac- 
terized (9, 23) and were gifts from Dr. Philip Guzelian. The 
antibody used to recognize the ethanol-inducible cytochrome 
P-45Oj (P-450IIE1) was a gift from Dr. Minor J. Coon. 
Erythromycin demethylase and aminopyrine demethylase 
activities were determined in liver microsomes by the Nash 
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FIG. 1. P-450prelated proteins present in liver microsomes prepared from choline-deficient rats. Microsomes (100 pg) prepared from control 
(con) and choline-deficient (CD,  rats were subjected to SDS-PAGE, and the separated proteins were then transferred electrophoretically to the 
nitrocellulose sheets. The representative blots shown were developed with the indicated antibodies as described in “Materials and Methods.” 
Two preparations of anti-P-450p IgG were used; one had been absorbed to female rat liver microsomes (A) and one had not (B). The slowly 
migrating protein identified only by the unabsorbed antibody (B)  is unlikely to be a cytochrome P-450. 1G8 (C) is a monoclonal antibody 
previously shown to recognize P-45Op 132). One CD rat had been pretreated with dexamethasone ICD-Dex). 
reaction (7).  Immunoinhibition of microsomal erythromy- 
cin demethylase activity was performed as previously de- 
scribed (8). 
Hybridization Studies. Total RNA was isolated from liver 
tissue by the method of Chirgwin et al. (24). subjected to 
agarose gel electrophoresis and transferred to nitrocellulose 
paper. Hybridizations were performed with 30-mer synthetic 
oligonucleotides corresponding to the hypervariable regions of 
two P-45OIIIA cDNAs identified as PCN-1 and PCN-2 (25) 
(or P450IIIA1 and P-45OIILA2, respectively 151). The hybrid- 
ization conditions used have been previously determined to 
selectively identify either PCN-1 or PCN-2 mRNA on 
Northern blots (25). P-450IIE1 mRNA was identified by 
hybridizing Northern blots with a P-450IIE-specific 30-mer 
synthetic oligonucleotide (26) under conditions previously 
shown to result in selective identification of P-450IIE 1 
mRNA (26). 
RESULTS 
Aminopyrine and Erythromycin Lkmethylase Ac- 
tivity. ERMBT and APBT were administered to CD and 
control rats. The production of CO, from aminopyrine 
was diminished by approximately 70%) in the CD rats 
compared with that observed in the controls (Table 1). 
This decrease is comparable to that previously reported 
in rats with established cirrhosis (19). When the 
ERMBT was administered, the production of CO, from 
erythromycin was also reduced approximately 70% in 
the deficient rats (Table 1). Furthermore, in the rats 
that had received both breath tests, there was excellent 
correlation between the production of CO, from each 
substrate (r = 0.99, data not shown). The comparable 
falls in the production of CO, from aminopyrine and 
TABLE 1. Results of APBT and ERMBT in rats on a control 
or CD diet 
APBT ERMBT” 
Diet c% n I n 
~ _ _ _ _ _  
Control 17.5 (2.2) 4 7.2 (1.1) 9 
CD 5.5 (1.7) 9 2.1 (0.7) 12 
Percent change - 69 ~ 71 
“Results expressed as percentage of administered “C exhaled in 1 
hr. Numbers in parentheses represent standard deviations from the 
mean. 
APBT = aminopyrine breath test; ERMBT = erythromycin breath 
test; CD = choline-deficient. 
erythromycin &d not support a selective loss of in uiuo 
P-450111 catalytic activity in the CD rats. However, it 
was possible that factors other than liver content of the 
responsible cytochromes P-450 became rate limiting in 
the production of CO, from these substrates in the CD 
rats. 
We therefore directly examined whether erythro- 
mycin demethylase activity was selectively reduced in 
microsomes prepared from the liver of each CD rat. As 
shown in Table 2, the ability to demethylate ami- 
nopyrine in the CD rat liver microsomes was approxi- 
mately 50% of that seen in control microsomes. Com- 
parable falls in microsomal aminopyrine demethylase 
activity have been reported previously in cirrhotic rats 
(19). Since the intrinsic ability of the hepatocyte to 
demethylate aminopyrine appears to be normal in the 
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TABLE 2. Results of erythromycin demethylase activity and aminopyrine demethylase activity in liver microsomes from rats 
on a control or CD diet 
ERMD APD ERMLP APW 
Diet (nmoi/midmg protein)’ (nmol/min/mg proteidb (nmol/midiver)b (nmol/minfliver)’ 
Control (n  = 9) 1.19 (.13)* 2.92 (.38) 363 (64) 888 (144) 
CD ( n  = 13) 0.89 (.29) 1.48 (.23) 256 (85) 425 (101) 
Percent change ~ 25 - 50 - 30 ~ 50 
“Determined as (specific activity) x (microsomal protein from entire liver). 
’Numbers in parentheses are standard deviations. 
‘p < 0.01 determined by an unpaired 1 test. 
ERMD = erythromycin demethylase; APD = aminopyrine demethylase: CD choline deficient. 
cirrhotic liver (191, the 50% decrease in specific activity 
may reflect dilution of the hepatocyte microsomes with 
those derived from other cell types (such as macrophages 
and bile ductular epithelia) that are abundant in the 
diseased liver. 
The erythromycin demethylase activity was also sig- 
nificantly lower in the hepatic microsomes prepared 
from CD rats compared with control microsomes (Table 
2). However, the fall in erythromycin demethylase 
activity was not greater than that in aminopyrine 
demethylase activity. This was also true when the 
respective demethylase activities were estimated for the 
entire liver (Table 2). Hence, the catalytic activity 
characteristic of P-450111 appeared to be relatively 
preserved in the CD liver microsomes, an observation 
that seemed at  odds with the report that at least one 
major P-450111 protein should be virtually absent (18). 
Zmmunochemical Analysis of Liver Microsomes. The 
liver microsomes prepared from each rat were analyzed 
on immunoblots to determine whether expression of 
P-450111 cytochromes had in fact been repressed in the 
CD rats. Immunoblots were first developed with a 
polyclonal antibody that selectively recognizes a major 
rat liver P-450111 cytochrome termed P-45Op (8 ,  11). In 
uninduced rats, P-45Op is generally detectable only in 
male liver ( 9 , l l ) .  The P-45Op specific antibody we used 
was prepared by absorbing anti-P-450p IgG (goat) to 
liver microsomes prepared from a female rat (11). The 
absorption step removes antibodies that recognize 
epitopes common to P-45Op and to other P450III 
proteins present in the female rat liver (9). As is shown 
in Figure lA, P-45Op was detected in the control liver 
microsomes but was barely detected, if a t  all, in the CD 
liver microsomes, essentially confirming the observa- 
tions of Murray et al. (18). The repression of P-45Op 
appeared to be a selective effect because there was no 
detectable difference between control and CD mi- 
crosomes in the content of immunoreactive P-45Oj 
(P-450IIE1) (data not shown). However, P-45Op could 
still be induced in the CD rat by pretreatment with 
dexamethasone (Fig. lA), indicating that the hepatocyte 
remained capable of expressing this enzyme. It therefore 
appeared that erythromycin demethylation was being 
catalyzed in the CD rat liver by enzymes other than 
It has recently been appreciated that rat liver contains 
P-450~.  
multiple P-450111 cytochromes (9, 25, 27). We reasoned 
that P-450111 cytochromes other than P-45Op (and those 
not recognized by the absorbed polyclonal antibody to 
P-45Op) might account for the relative preservation of 
erythromycin demethylase activity in the CD rat liver. 
Immunoblots of the rat liver microsomes were therefore 
developed with the unabsorbed anti-P-450p IgG, which 
would be expected to recognize multiple members of the 
P-450111 gene family. As shown in Figure lB, blots 
developed with the unabsorbed IgG confirmed that the 
concentration of P-45Op had been greatly reduced in the 
CD microsomes. However, a second protein band was 
recognized by the unabsorbed antibody in the CD 
microsomes, reflecting a protein that migrated more 
rapidly than did P-45Op on the gels (Fig. 1B). To 
estimate the proportion of erythromycin demethylase 
activity that was being catalyzed by proteins recognized 
by this antibody, microsomes prepared from represen- 
tative control and CD rats were incubated with the 
anti-P-450p IgG or with nonimmune IgG (10 mg/nmol 
spectrally determined P-450) before measuring catalytic 
activity toward this substrate. Erythromycin demeth- 
ylase activity was inhibited to a comparable extent in 
liver microsomes prepared from each animal (54% and 
62% inhibition in control and deficient microsomes, 
respectively, compared with the activity seen in the 
microsomes containing nonimmune IgG). We concluded 
that the proteins recognized by the nonabsorbed anti- 
P-45Op IgG catalyzed most erythromycin demethylase 
activity in the livers of both CD and control animals. 
We next used monoclonal antibodies in an attempt to 
determine the identity of the P-450prelated protein 
that appeared to be induced in the CD liver microsomes. 
As shown in Figure lC, the induced protein appeared to 
be recognized by a monoclonal antibody termed 1G8. 
1G8 has been previously shown to recognize P-45Op (9), 
and the absence of P-45Op in the CD microsomes was 
also confirmed using this antibody (Fig. 1 0 .  In addition, 
1G8 recognizes a second protein that is male specific in 
uninduced rats, and this protein migrates slightly faster 
than P-45Op on SDS-PAGE (9,28). As shown in Figure 
lC, 1G8 appeared to recognize the P-450prelated 
protein present in the CD microsomes, and this protein 
exactly comigrated with the faster migrating protein 
present in control liver microsomes (hereafter referred 
to as “ ~ 2 ” ) .  
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FIG. 2. Liver microsornes reacted with the nionoclonal antibody 
13-7-10. Liver microsomes prepared from control male f c o n - M / .  
control female fcon-FJ and cholinr-deficient (cnj male rats were 
subjected to SDS-PAGE 140 ) ~ g )  The separated proteins were 
transferred to nitrocellulose sheets and reacted with the monoclonal 
antibody 13-7-10 as described in "Materials and Methods." 
Finally, the immunoblots were developed with an- 
other monoclonal antibody, termed 13-7-10, (23). that 
identifies additional P-450prelated proteins present in 
liver microsomes prepared from untreated male and 
female rats (9, 28). As shown in Figure 2, the reactive 
protein present in untreated male liver migrates more 
rapidly on PAGE than does the female reactive protein, 
as has been previously reported (9, 28). It has been 
shown (9) that the 13-7-10 reactive protein present in 
control male liver microsomes exactly comigrates with 
p2. Liver microsomes prepared from our CD (male) rats 
contained a reactive protein indistinguishable from the 
male-specific 13-7-10 reactive protein on immunoblots 
(Fig. 2). In addition, the specific content of this immu- 
noreactive protein appeared to be identical in mi- 
crosomes prepared from either the CD or control rats 
(Fig. 2 and data not shown). 
To see whether repression of P-45Op and induction of 
the related protein were due to an immediate effect of 
the diet, rats were placed on the CD and control diets. 
Members of each treatment group were killed 2 wk later 
and at the end of each consecutive month on the diets. 
Microsomes prepared from each rat were analyzed on 
immunoblots developed with the monoclonal antibody 
2 w k  2 w k  1mo 2mo 3mo 7mo 7mo 




Pic;. 3. The loss of immunoreactive P-45Op and the appearance of an 
irnmunochernically related protein fp21 in liver microsomes as a 
function of time on the CD diet. Rats were killed after the indicated 
intervals on the control fconi or choline-deficient fCD! diets. Liver 
rnicrosomes were prepared and analyzed using 75 p,g rnicrosomal 
protein and methods noted previously. Immunoblots were developed 
with the monoclonal antibody 1G8. 
1G8. As shown in Figure 3, the loss of immunoreactive 
P-45Op and the induction of the related protein occurred 
gradually over time on the CD diet. 
mRNA Studies. To date only two complete cDNAs 
corresponding to rat P-450111 genes have been cloned 
and sequenced, and these have been termed PCN-1 and 
PCN-2 (251, which correspond to the genes P450IIIA1 
and P450IIIA2, respectively ( 5 ) .  We sought to determine 
whether regulation of these mRNAs was altered in the 
CD rat. In addition, by comparing PCN-1 and PCN-2 
mRNA content in control and CD rat livers, we hoped it 
would be possible to tentatively identify the P-450111- 
related proteins recognized by our antibodies. This 
would, however, require that the loss of P-45Op and the 
appearance of the P-450111-related protein (Fig. 3) had 
resulted in the CD rat from alterations in regulation at 
steps before mRNA translation. Accordingly, total RNA 
extracted from the livers of control and CD rat livers was 
analyzed on Northern blots hybridized with 30-mer 
synthetic oligonucleotide probes corresponding to hy- 
pervariable regions of PCN-1 and PCN-2 cDNA (25). 
PCN-1 RNA has been reported to be inducible by 
dexamethasone but not to be readily detected in liver 
RNA prepared from control male or female rats (25). 
Our results confirmed these observations (Fig. 4). We 
also found that PCN-1 mRNA was undetectable in the 
livers from each of the CD rats (Fig. 4). 
We found that PCN-2 mRNA was readily detected in 
male but not female liver and was not inducible by 
dexamethasone (Fig. 4); this confirms prior reports (25). 
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FIG. 4. Identification of P-450111 mRNAs in the livers of choline- 
deficient rats. Total RNA was extracted from livers obtained from 
dexamethasone-pretreated female fDEX-fl, control male (Con-M), 
control female (Con-F) or choline-deficient male (CD) rats as described 
in methods. The RNA (10 wg) was subjected to agarose gel electro- 
phoresis and then transferred to nitrocellulose sheets by capillary 
action. Shown above is an identical blot hybridized with each of the 
indicated 30-mer synthetic oligonucleotides. (The sheet was boiled 
between each hybridization). PCN-1 and PCN-2 are the only rat 
P-450111 cDNAs that have been identified. To assure that comparable 
amounts of RNA were being analyzed from each rat, the blot was also 
hybridized with a synthetic oligonucleotide specific for P-450IIEl. 
Among individual male liver RNA samples, the intensity 
of hybridization with the PCN-2 probe varied re- 
markably (Fig. 4). However, there were no consistent 
differences in PCN-2 RNA concentrations between the 
CD and control liver RNA (Fig. 4). Moreover, when liver 
microsomes prepared from each of these rats were 
subjected to immunoblot analysis, there were no obvious 
correlations between the concentrations of any of the 
P-450prelated proteins and liver content of PCN-2 
mRNA (data not shown). To assure that comparable 
amounts of mRNA from each rat had been analyzed, the 
blots were stripped and rehybridized with a 30-mer 
synthetic oligonucleotide specific for the ethanol- 
inducible cytochrome P-45Oj (P-450IIE1) mRNA (26). 
We observed generally higher amounts of P-450IIE 1 
mRNA in female than in male rats (Fig. 4 and data not 
shown), and this has been observed by others (14). No 
consistent differences in hybridization intensity were 
observed between the CD and control liver RNA samples 
(Fig. 4). 
DISCUSSION 
We have confirmed that the liver content of a major 
erythromycin demethylase (P-45Op) is markedly re- 
duced in a commonly used rat model for chronic liver 
disease (Figs. 1 and 3). Contrary to our initial hy- 
pothesis, however, the production of CO, from erythro- 
mycin in these rats was not more significantly impaired 
than that from aminopyrine (Table 1). At least in part, 
this appears to result from relative preservation of 
erythromycin demethylase activity in the diseased liver 
(Table 2). Our observations are supported by those of 
Murray et al. (181, who reported that another catalytic 
activity characteristic of P-450111 cytochromes (tes- 
tosterone 6P-hydroxylase activity) also appeared to be 
relatively preserved in CD rat liver microsomes. 
We believe that our immunochemical analysis of the 
CD liver microsomes provides an explanation for these 
observations. Although the concentration of P-45Op was 
dramatically reduced in the CD rat liver microsomes, the 
concentration of one P-450111-related protein appeared 
to be similar in control and CD rat liver microsomes (Fig. 
2). Moreover, the microsomal concentration of another 
P-450111-related protein was markedly increased in the 
CD liver microsomes (Figs. 1 and 3). Because the 
non-P-450p proteins identified by the monoclonal anti- 
bodies have not yet been purified, it has not been possible 
to directly demonstrate that these proteins are capable 
of erythromycin demethylation. Nonetheless, most 
erythromycin demethylase activity in CD liver mi- 
crosomes (essentially lacking P - 4 5 0 ~ )  could be inhibited 
by preincubation with anti-P-450p I&, indicating that 
most of this activity was due to P-450prelated proteins. 
Our observations suggest that the loss of erythromycin 
demethylase activity attributable to P-45Op is compen- 
sated for by the induction of another P-450111 cy- 
tochrome capable of catalyzing this reaction. 
It should be pointed out that the reciprocal changes in 
the concentrations of P-45Op and the second reactive 
protein (Fig. 3) might also be compatible with P-45Op 
degradation to a slightly smaller protein in the CD liver. 
However, this seems unlikely for several reasons. First, 
both the unabsorbed and absorbed polyclonal antibody 
preparations appeared to have higher affinity for P-45Op 
than for the second protein, whereas the reverse 
appeared to be the case with the monoclonal antibody 
1G8 (Fig. 1). This suggests that P-45Op contains multiple 
epitopes not present in the protein induced in the CD 
liver. Second, the CD rat hepatocytes were clearly 
capable of expressing P-45Op when pretreated with 
dexamethasone (Fig. 1A). Finally, two attempts to purify 
the induced protein from our CD liver microsomes have 
failed using techniques similar to those used to purify 
P-45Op (S. Wrighton, Personal communication, 1989). 
Vol. 12, No. 6. 1990 1’-45OI11 (‘YTOCHROMES IN C‘HOLINE-DEFICIENT RATS 1377 
These observations suggest that the protein induced in 
the CD liver is related to, but structurally distinct from. 
P-45Op. We believe that this is the first evidence to date 
that some cytochromes P-450 may actually be induced 
by chronic liver disease or prolonged nutritional defi- 
ciency. 
Several conclusions can be drawn from our data about 
the mechanisms involved in the differential expression 
of P-450111 proteins we observed in the CD animals. 
First, because the reciprocal changes in the specific 
concentrations of P-45Op and the related protein were 
only evident after weeks on the diet (Fig. 3), they were 
not acute effects of the nutritional deficiency. However. 
since the CD rats gained weight much more slowly than 
did the controls, it is possible that starvation alone may 
account for the differential regulation we observed. 
Second, it is unlikely that the changes we observed 
reflect “feminization of the liver” as has been previously 
postulated (18). The CD rats appeared to maintain 
expression of a male-specific P-450111-related protein. 
and a related protein that is female-specific was never 
detected (Fig. 2 ). In addition, the P-450111-related 
protein that was induced in the CD liver was indistin- 
guishable from a protein that is male specific in control 
animals (Figs. 1C and 3) .  Finally, the male-specific 
mRNA PCN-2, was readily detected in each CD rat liver 
(Fig. 4). 
Our observations also supply some additional infor- 
mation regarding the P-450111 gene family. When 
uninduced male rat liver microsomes are subjected to 
SDS-PAGE, the 13-7-10 reactive protein (Fig. 2) exactly 
comigrates with the faster migrating 1G8 reactive 
protein (9). It had therefore not been previously possible 
to show that these were distinct proteins rather than a 
single protein sharing both epitopes (9). In the CD liver. 
however, the IG8-reactive protein was significantly 
induced, whereas the microsomal concentration of the 
13-7-10 reactive protein was unchanged, indicating that 
the proteins are not identical. Unfortunately, we were 
unable to use our rats to indicate whether any of the 
three immunoreactive proteins reflected expression of 
either the PCN-1 or PCN-2 gene. The concentrations of 
PCN-1 or PCN-2 mRNA did not appear to correlate well 
with the specific content of any of the P-450prelated 
proteins in the livers analyzed (Fig. 4). However. 
regulation of these proteins in the CD rats may not be at 
the level of transcription. 
It is tempting to speculate that the loss of P-45Op may 
have physiological significance in these animals. Selye 
(29) showed that rats pretreated with the prototypical 
inducer of P-450p, pregnenolone 16a-carbonitrile, were 
resistant to the liver toxicity of many drugs. This 
appeared to result from an increased ability to detoxify 
and/or eliminate potential toxins. Furthermore, others 
have shown that pregnenolone 16u-carbonitrile-treated 
rats are resistant to dimethylnitrosamine-induced hepa- 
tomas (30). The selective loss of P-45Op in the CD rat 
may therefore result in decreased detoxification ability, 
which may contribute to the progressive liver injury 
associated with the diet. On the other hand, some 
P-450111 cytochromes appear to be involved in the 
bioactivation of various mycotoxins, including aflatoxin 
B (31, 32). Differential effects on regulation of P-450111 
cytochromes may therefore contribute to the high 
incidence of spontaneous hepatomas observed in rats 
maintained on the deficient diet for more than 7 mo (33). 
It has in fact been postulated that hepatomas observed 
in these rats result from enhanced susceptibility to 
aflatoxin present in trace amounts in the diet (34). 
Because the P-450IIE1 cytochrome has been widely 
implicated in carcinogenesis ( 14 and references therein), 
our incidental observations indicating that regulation of 
this enzyme did not appear to be altered in the CD rat 
liver may also be important. 
Finally, it should not be concluded from our studies 
that the ERMBT will offer no advantage over the APBT 
in monitoring liver function in patients. Although 
P-450111 cytochromes are highly conserved in mammals 
(7) and are major constitutive enzymes in human liver 
(4, 6), species differences in their regulation exist (7) .  
Furthermore, the P-450111 cytochromes have been 
characterized with regard to induction or inhibition by 
medications and are not induced by ethanol (6-14). The 
use of erythromycin therefore has theoretical advan- 
tages over aminopyrine where the responsible enzymes 
have yet to be identified. Clinical studies using the 
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